The outcome of cross-priming during virus infection is not directly linked to the ability of the antigen to be cross-presented

European Journal of Immunology

Volumn 40, Issue 8, 2010, Pages 2190-2199

  Alatery, Attiya ^a   Tarrab, Esther ^b   Lamarre, Alain ^b   Basta, Sameh ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Antigen presentation processing; Peptides epitopes; Viral antigens

Indexed keywords

EPITOPE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; ARENAVIRIDAE INFECTIONS; CELL LINE; CELL PROLIFERATION; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77956129653     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939973     Document Type: Article

References (37)

1. Lenz, L. L., Butz, E. A. and Bevan, M. J., Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 2000. 192: 1135-1142.
2. Sigal, L. J. and Rock, K. L., Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 2000. 192: 1143-1150.
3. Debrick, J. E., Campbell, P. A. and Staerz, U. D., Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 1991. 147: 2846-2851.
4. Basta, S. and Alatery, A., The cross-priming pathway: a portrait of an intricate immune system. Scand. J. Immunol. 2007. 65: 311-319.
5. Shen, L. and Rock, K. L., Priming of T cells by exogenous antigen crosspresented on MHC class I molecules. Curr. Opin. Immunol. 2006. 18: 85-91.
6. den Haan, J. M. and Bevan, M. J., Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr. Opin. Immunol. 2001. 13: 437-441.
7. Basta, S., Stoessel, R., Basler, M., van den Broek, M. and Groettrup, M., Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J. Immunol. 2005. 175: 796-805.
8. Dunbar, E., Alatery, A. and Basta, S., Cross-priming of a single viral protein from lymphocytic choriomeningitis virus alters immunodominance hierarchies of CD8(+) T cells during subsequent viral infections. Viral Immunol. 2007. 20: 585-598.
9. Freigang, S., Eschli, B., Harris, N., Geuking, M., Quirin, K., Schrempf, S., Zellweger, R. et al., A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently crossprimes CD8(+) T cell responses. Proc. Natl. Acad. Sci. USA 2007. 104: 13426-13431.
10. Pavelic, V., Matter, M. S., Mumprecht, S., Breyer, I. and Ochsenbein, A. F., CTL induction by cross-priming is restricted to immunodominant epitopes. Eur. J. Immunol. 2009. 39: 704-716.
11. Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J. et al., CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004. 304: 1318-1321.
12. Wolkers, M. C., Brouwenstijn, N., Bakker, A. H., Toebes, M. and Schumacher, T. N., Antigen bias in T cell cross-priming. Science 2004. 304: 1314-1317.
13. Lev, A., Takeda, K., Zanker, D., Maynard, J. C., Dimberu, P., Waffarn, E., Gibbs, J. et al., The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 2008. 28: 787-798.
14. Otahal, P., Hutchinson, S. C., Mylin, L. M., Tevethia, M. J., Tevethia, S. S. and Schell, T. D., Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope. J. Immunol. 2005. 175: 700-712.
15. Froeschke, M., Basler, M., Groettrup, M. and Dobberstein, B., Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-C. J. Biol. Chem. 2003. 278: 41914-41920.
16. van der Most, R. G., Murali-Krishna, K., Lanier, J. G., Wherry, E. J., Puglielli, M. T., Blattman, J. N., Sette, A. et al., Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 2003. 315: 93-102.
17. van der Most, R. G., Murali-Krishna, K., Whitton, J. L., Oseroff, C., Alexander, J., Southwood, S., Sidney, J. et al., Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 1998. 240: 158-167.
18. Steinman, R. M., Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008. 29: 319-324.
19. Bruns, M., Kratzberg, T., Zeller, W. and Lehmann-Grube, F., Mode of replication of lymphocytic choriomeningitis virus in persistently infected cultivated mouse L cells. Virology 1990. 177: 615-624.
20. Probst, H. C., Tschannen, K., Gallimore, A., Martinic, M., Basler, M., Dumrese, T., Jones, E. et al., Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 2003. 171: 5415-5422.
21. Khan, S., de Giuli, R., Schmidtke, G., Bruns, M., Buchmeier, M., van den Broek, M. and Groettrup, M., Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J. Immunol. 2001. 167: 4801-4804.
22. Kotturi, M. F., Scott, I., Wolfe, T., Peters, B., Sidney, J., Cheroutre, H., von Herrath, M. G. et al., Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 2008. 181: 2124-2133.
23. Palmowski,M. J., Gileadi,U., Salio,M., Gallimore, A.,Millrain, M., James, E., Addey, C. et al., Role of immunoproteasomes in cross-presentation. J. Immunol. 2006. 177: 983-990.
24. Basler, M., Youhnovski, N., Van Den Broek, M., Przybylski, M. and Groettrup, M., Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J. Immunol. 2004. 173: 3925-3934.
25. Gil-Torregrosa, B. C., Lennon-Dumenil, A. M., Kessler, B., Guermonprez, P., Ploegh, H. L., Fruci, D., van Endert, P. et al., Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 2004. 34: 398-407.
26. Green, D. R., Ferguson, T., Zitvogel, L. and Kroemer, G., Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 2009. 9: 353-363.
27. Ramirez, M. C. and Sigal, L. J., Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 2002. 169: 6733-6742.
28. Alatery, A., Siddiqui, S., Chan, M., Kus, A., Petrof, E. O. and Basta, S., Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state. Immunol. Cell. Biol. 2010. 88: 3-12.
29. Willis, R. A., Kappler, J. W. and Marrack, P. C., CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. USA 2006. 103: 12063-12068.
30. Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J. and Marrack, P., T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 2000. 192: 1105-1113.
31. Chen, W., Anton, L. C., Bennink, J. R. and Yewdell, J. W., Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 2000. 12: 83-93.
32. Shen, Z., Reznikoff, G., Dranoff, G. and Rock, K. L., Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997. 158: 2723-2730.
33. Kovacsovics-Bankowski, M. and Rock, K. L., Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur. J. Immunol. 1994. 24: 2421-2428.
34. Battegay, M., Cooper, S., Althage, A., Banziger, J., Hengartner, H. and Zinkernagel, R. M., Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 1991. 33: 191-198.
35. Alatery, A. and Basta, S., An efficient culture method for generating large quantities of mature mouse splenic macrophages. J. Immunol. Methods 2008. 338: 47-57.
36. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer- Williams, M. G., Bell, J. I., McMichael, A. J. et al., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
37. Siddiqui, S., Tarrab, E., Lamarre, A. and Basta, S., Altered immunodominance hierarchies of CD8+ T cells in the spleen after infection at different sites is contingent on high virus inoculum. Microbes Infect. 2010. 12: 324-330